Addressing Challenges in Diagnosis and Treatment of Low-Grade Upper Tract Urothelial Carcinoma

To participate in this activity, please:

Upper tract urothelial carcinoma (UTUC) has many similarities to bladder carcinoma, but also some important differences. Join Dr. Seth Lerner, as he contrasts these 2 diseases, as well as important differences between low-grade and high-grade UTUC. Dr. Lerner highlights important considerations in the instruments, imaging, and biopsy techniques for diagnosing low-grade UTUC. Surgical options are considered, with a focus on patient selection for endoscopic nephron-sparing surgery. The safety and efficacy of intracavitary therapy are discussed, with an emphasis on mitomycin for pyelocalyceal solution.

Course Credit:

0.75 AMA PRA Category 1 CreditsTM
0.75 ANCC Contact Hours
0.75 CA-BRN Contact Hours
0.25 Pharmacology Hours


Opens: 2021-08-20
Closes: 2022-08-20

Target Audience:

This activity was developed for urologists, oncologists, advanced practitioners, oncology nurses, and other healthcare providers involved in the care of patients with low-grade upper tract urothelial carcinoma.

This educational activity is supported by an educational grant from UroGen.

    Presenting Faculty

  • Seth Lerner, MD

    Professor, Urology
    Beth and Dave Swalm Chair in Urologic Oncology
    Director of Urologic Oncology
    Director of the Multidisciplinary Bladder Cancer Program
    Baylor College of Medicine Medical Center
    Houston, Texas